Micky, the firm’s Founding and Managing Partner, is recognized as one of Israel’s leading corporate lawyers. His diverse practice encompasses corporate, securities, technology, and cross-border matters.
Micky has earned an excellent reputation for working with private and public companies on securities offerings, fundraising, M&A transactions, transfers of control, and reorganizations.
Micky is greatly respected as a legal advisor to public companies traded on both Israeli and foreign stock exchanges, as well as to foreign investors with stakes in Israeli publicly-traded companies.
In the technology sphere, Micky counsels a variety of early and later-stage companies, as well as leading venture capital, corporate venture, and private-equity investors. He also oversees prominent cross-border technology-related transactions.
Micky is a well-known figure in the Israeli hi-tech ecosystem. He lectures on a regular basis to various Israeli accelerators and incubators, in addition to serving as a mentor for young entrepreneurs.
Micky has consistently been ranked in the prestigious Chambers and Partners directory as a leading lawyer in the Corporate/M&A and TMT practice area. The guide describes him as “really brilliant and very straightforward. Problem solver.” The guide also ranked him as a leading lawyer in the field of Private Wealth Law.
The IFLR1000 directory also steadily ranks Micky for his work in the Capital Markets: Equity and M&A sector. The ILFR1000 pronounced him as “very practical and incisive and always constructive with his advice.”
In addition to his work with the firm, Micky was appointed as the Middle East Liaison Officer of the IBA Law Firm Management Committee.
Tel Aviv University (LL.B.) 1992
Member of Israel Bar Association since 1993
News and updates - Michael Barnea:
Barnea Represented Bridgepoint in the Acquisition of Qualitest
Our firm represented the private equity group Bridgepoint in the acquisition of control in the Israeli software testing company Qualitest from Marlin Equity Partners.
Barnea Represented Johnson & Johnson Innovation in an Investment Round in DayTwo
Our firm represented JJDC in its follow on investment in the Israeli medtech company DayTwo, as part of a $31 million series B round.
Barnea Represented Johnson & Johnson Innovation in an Investment Round in Techsomed
Micky Barnea, Ariella Dreyfuss, Itay Gura, Mayer Winkler, and Ido Freund represented Johnson & Johnson Innovation in an investment round in the Israeli medtech startup Techsomed Medical Technologies Ltd. Founded in 2012, Techsomed has developed an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. Techsomed intends to use the funding toward receiving regulatory approval in the US, Europe, and Japan.
JJDC led the company's current round of financing, which included both former and new investors, such as Screen Holdings, the Alfred Mann Institute at the Technion (AMIT), NextLeap Ventures, and Axil Capital.